However, we found that, in participants without history of heart disease and with plasma concentrations of ANP and BNP within the normal range, higher values associate with lower markers of vascular and metabolic risk and with improved cardiac performance [15,16] (Figure 1). The gene discussed is NPPB; the disease is heart disorder.